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Autoimmune Diseases Co-occurring Within Individuals
and Within Families
A Systematic Review
Emily C. Somers,*† Sara L. Thomas,* Liam Smeeth,‡ and Andrew J. Hall*
Background: Autoimmune diseases have been observed to coexist
both within individuals and within families. It is unclear whether
clinical reports of comorbid autoimmune diseases represent chance
findings or true associations. This systematic review evaluates the
current level of evidence on the coexistence of selected autoimmune
diseases within individuals and families. We reviewed the associa-
tions among 4 TH1-associated autoimmune diseases: insulin-depen-
dent diabetes mellitus, autoimmune (Hashimoto) thyroiditis, rheu-
matoid arthritis, and multiple sclerosis.
Methods: Studies quantifying the coexistence between the selected
diseases, published through March 2004, were identified from Med-
line and Embase searches. Study eligibility was determined on the
basis of preestablished criteria, and relevant data were extracted
according to a fixed protocol. We determined the prevalence of
comorbid autoimmune disease according to index disease and then
compiled summary statistics. Heterogeneity among studies was
assessed by exact likelihood ratio tests and Monte Carlo inference.
Results: We found 54 studies that met the eligibility criteria. Of
these, 52 studies examined the coexistence of disease within indi-
viduals and 9 studies examined within-family associations. The
majority of studies were uncontrolled and did not account for
confounding factors. There was substantial evidence for heteroge-
neity among studies. Although inconclusive, the data appear to
support an increased prevalence of autoimmune thyroiditis among
patients with rheumatoid arthritis and those with insulin-dependent
diabetes mellitus, and an inverse association between rheumatoid
arthritis and multiple sclerosis.
Conclusion: Although the available evidence does not permit firm
conclusions regarding comorbidities among the selected autoimmune
diseases, results are sufficiently suggestive to warrant further study.
(Epidemiology 2006;17: 202–217)
Autoimmune diseases include a diverse group of chronicdisorders associated with substantial public health im-
pact.1 Anecdotal evidence suggests that autoimmune diseases
tend to coexist both within individuals and within families,
and the concept of an autoimmune diathesis is widely ac-
cepted. However, the patterns of association among autoim-
mune diseases have not been evaluated in a systematic fashion,
and it is unclear whether clinical reports of comorbid autoim-
mune diseases represent chance findings or true associations.
Animal models demonstrate a clear association be-
tween different types of autoimmune disorders. For example,
nonobese diabetic mice frequently develop thyroiditis and
sialoadenitis in addition to autoimmune insulin-dependent
diabetes.2 These mice crossed with KRN mice (a T-cell
receptor transgenic line) develop a disease, closely resem-
bling human rheumatoid arthritis.3 SJL mice (a model of
experimental autoimmune encephalomyelitis) are highly sus-
ceptible to a number of experimentally induced autoimmune
diseases.4 Although genetic background is important, exoge-
nous factors (such as level of microbial exposure or xenobi-
otics) can modulate the development of disease in autoim-
mune-prone animal models.5–7
Common features in the immunoepidemiology of var-
ious autoimmune diseases are recognized, and reports of
shared risk factors are emerging.8–10 However, the etiologies
of most autoimmune diseases remain poorly understood.
Because autoimmune diseases are conventionally treated by
separate medical specialties according to type of organ in-
volvement, there are missed opportunities to study these
diseases as a group. We are interested in the premise that
interaction between genetic background and early life program-
ming due to environmental exposures may result in general
susceptibility to autoimmune disease. Characterization of the
extent to which particular combinations of autoimmune diseases
occur in excess of that expected by chance may offer insight into
shared pathophysiological mechanisms.
We undertook a systematic literature review to quantify
the coexistence of selected autoimmune diseases within in-
dividuals and families. We reviewed the associations among
4 autoimmune diseases: insulin-dependent diabetes mellitus
(IDDM), autoimmune (Hashimoto) thyroiditis (AIT), rheu-
matoid arthritis (RA), and multiple sclerosis (MS). We chose
to focus on these diseases for several reasons. Evidence of
associations between these diseases in animal models imparts
plausibility for their coexistence in humans. Moreover, these
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diseases are sufficiently common, in contrast to many other
autoimmune diseases, to provide a reasonable expectation of
detecting them in combination.
A further consideration is that these disorders are
widely considered to be TH1-associated. Mosmann et al
11
described 2 functional subsets of T-helper cells in mice, TH1
and TH2, characterized by different patterns of cytokine
secretion. TH1 and TH2 cells are also distinguishable on the
basis of chemokine receptors.12 Immune-mediated disorders
in mouse models can be classified as TH1- or TH2-associated
according to the predominant cytokine profile. Although this
is an oversimplified approach for the classification of disease
in humans, and additional subsets of T cells have been more
recently identified (Th3 and Tr1),13 the 4 diseases that we
included in this review have nonetheless been described as
having characteristics of TH1 predominance.
14,15 One can
speculate that mutual genetic or environmental factors influenc-
ing cytokine regulation or T-cell polarization are relevant to
TH1-associated disorders, and that these conditions would tend
to coexist within individuals and possibly within families.
METHODS
Identification of Studies and Data Extraction
We identified studies quantifying the coexistence of
selected autoimmune diseases, published through March
2004, from Medline (Ovid) and Embase electronic databases.
These databases cover literature from 1966 and from 1980,
respectively. Identification of articles was performed by
searching the databases on a combination of thesaurus terms.
No language restrictions were applied. In Medline, thesaurus
terms for the 4 prespecified autoimmune diseases were ex-
ploded for “diabetes mellitus, type 1,” “multiple sclerosis,”
“arthritis, rheumatoid,” and “thyroiditis, autoimmune” or
“thyroiditis, subacute” or “thyroid diseases.” For all diseases,
the search was restricted to the subheadings of complications,
epidemiology, etiology, genetics, and physiopathology. The
results from each search were crosstabulated with all the
other searches to identify publications with any combination
of at least 2 of the specified diseases. A similar search
strategy was used in Embase (list of terms available on
request). Review articles published within the last 5 years on
the epidemiology of each of the autoimmune diseases were
also identified. Reference lists from all relevant articles were
examined for studies that were not captured by the comput-
erized searches. A textbook on rheumatic disease epidemiol-
ogy16 was also reviewed.
Studies were eligible for inclusion in the review if the
coexistence of 2 or more prespecified autoimmune diseases,
either within individuals or among first-degree relatives (par-
ents, siblings, children), was reported. Uncontrolled case
series were eligible if a denominator was documented. For
studies of individuals, the denominator was the total number
of index disease cases. For family studies, the denominator
was considered to be the number of relatives rather than the
number of families. Studies were excluded if: (1) they were
clinical/laboratory studies that selected patients based on
prespecified proportions of comorbid autoimmune conditions
(eg, a case–control study of patients with RA with IDDM
versus patients with RA without IDDM); (2) they were
restricted to seroprevalence of autoantibodies rather than
clinical disease (because autoantibodies can occur in healthy
individuals); (3) there was insufficient distinction between
diagnostic categories (eg, type 1 vs type 2 diabetes, rheuma-
toid arthritis vs osteoarthritis, autoimmune vs nonautoim-
mune thyroid disease); (4) they were restricted to families
having multiple members with autoimmune diseases; (5) they
were restricted to women during pregnancy or the postpartum
period; or (6) their results were not sufficiently clear to
determine prevalence. Furthermore, articles were excluded if
autoimmune disease coexistence was reported in the context
of a known genetic syndrome, eg, autoimmune polyglandular
syndrome.17 For studies with index disease case groups
meeting eligibility criteria, but control groups failing to meet
criteria (eg, cross-sectional studies that recruited “healthy
controls”), only data regarding the index disease case groups
were included in this review. For the purposes of this review,
we did not consider patients with only “subclinical” hypo-
thyroidism (elevated thyroid-stimulating hormone TSH but
normal thyroid function, ie, normal circulating concentrations
of free T3 and T4) to have autoimmune thyroiditis.
18
A primary reviewer screened all titles and abstracts of
publications identified by the literature search for eligibility.
Articles were rejected if they clearly did not meet eligibility
criteria. The full text of all articles possibly meeting inclusion
criteria was obtained and screened. A secondary reviewer was
consulted in cases in which eligibility of the article was unclear.
We categorized each study according to index and
comorbid disease. For example, if a series of patients with
RA was evaluated for the presence of another disease, we
considered RA to be the index disease and any secondary
condition as comorbid. Controls (when applicable) were
persons who did not have the index disease but may have
been positive for the comorbid disease. For the family stud-
ies, we use the term “case proband” to represent individuals
with the index disease and the term “control proband” for
nonindex disease controls. Similarly, “case relatives” are
relatives of the case probands, and “control relatives” are
relatives of the control probands. We included any results
regarding the prevalence of comorbid disease among pro-
bands in the section on intraindividual disease.
We used a standardized data collection form to extract
data, including study design and population, number of index
disease cases and controls, incidence/prevalence of coexistent
autoimmune diseases, diagnostic criteria used for index and
comorbid diseases, potential confounding factors (eg, sex,
age), and crude and adjusted relative risk estimates (odds
ratios OR or standardized prevalence ratios, as appropri-
ate) with 95% confidence intervals (CIs). The effect esti-
mates refer to comorbid autoimmune diseases within index
disease cases compared with controls. For family studies,
data collection was modified to include the number of
index disease and control probands, and the number and
proportion of relatives of probands with coexistent auto-
immune diseases.
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Analysis
We computed comorbid autoimmune disease preva-
lence and corresponding exact binomial 95% CIs separately
for index disease cases and controls. For studies that included
raw data from control or reference groups without presenta-
tion of risk estimates relative to the index group, we calcu-
lated measures of relative risk (RR) and 95% CIs. We used
ORs and exact 95% CIs for case–control studies. For studies
including population-based reference data, we calculated
standardized prevalence ratios (SPRs) and CIs based on the
Poisson distribution for comparison of the observed number
of comorbid cases with that expected based on the population
reference values. We assessed heterogeneity among studies
(within each combination of diseases) by exact likelihood
ratio tests and Monte Carlo inference to determine whether it
was appropriate to obtain pooled estimates of prevalence or
relative risk. We conducted statistical analyses using Stata
version 8 (Stata Corp., College Station, TX) and StatXact
version 6 (Cytel Software Corp., Cambridge, MA).
RESULTS
Studies Identified
We identified 1187 publications from the Medline and
Embase searches, of which we judged 86 to be potentially
eligible based on initial screening. Of these, 39 met inclusion
criteria. We identified a further 67 articles from reference lists
for screening, of which 15 fit inclusion criteria. Thus, in total,
we included 54 articles in this review. Studies are summa-
rized in Tables 1 and 2.
Comorbidity of Autoimmune Diseases
Within Individuals
Fifty-two studies examined the coexistence within in-
dividuals of at least 2 of the selected autoimmune diseases.
Only 16 of these studies had control groups or presented
expected values based on population data. For each of the
within-individual studies, the prevalence estimates and 95%
CI for comorbid autoimmune diseases within index disease
cases are displayed in a forest plot (Fig. 1). For context,
background prevalence estimates based on data from a sys-
tematic review of epidemiologic data from the United States
by Jacobson et al19 are as follows: RA 0.86%, IDDM 0.19%,
AIT 0.79% adults/0.53% children (10–19 years), and MS
0.06%. However, these estimates provide only a crude com-
parison for the studies summarized in this review, because the
populations varied considerably in terms of demographic
structures, geographic locations, and time periods.
With the exception of comorbid RA among MS index
cases, there was strong evidence of heterogeneity for all
disease combinations (P for heterogeneity all 0.0001).
Given such heterogeneity, we did not focus on pooled esti-
mates or perform an overall meta-analysis. Study findings are
reviewed here according to each index disease category.
Rheumatoid Arthritis
Eleven intraindividual studies included RA as the index
disease; one additional study included juvenile rheumatoid
arthritis (JRA) index cases. Five studies examined the coex-
istence of IDDM20–24 with IDDM prevalence among RA
index cases ranging from 0.32% to 5.95%. Of the 2 studies
with controls,21,22 ORs were undefined, because neither study
found any coexistent IDDM in the control groups. Neither
study adjusted for confounders such as sex or age. The only
population-based study, which arguably followed the most
rigorous methodology, found no association between IDDM
and RA when standardized to the source population.
Eight studies20,22,25–30 examined the prevalence of co-
morbid AIT (autoimmune thyroiditis) among RA index cases,
with estimates ranging from 0.5% to 9.8%. A ninth study of
JRA index cases found 4.5% prevalence for comorbid AIT.31
Of the 4 controlled studies,22,25,27,28 all found increased odds
ratios for AIT among the RA cases versus controls, although
CIs were wide and overlapped one in 2 cases. One of the
studies was from a postmortem setting, limiting its compara-
bility to the other studies.25 The only population-based study
found no association based on expected values from the
source population.20
Insulin-Dependent Diabetes Mellitus
Twenty-seven studies32–58 with IDDM as the index
disease were identified. All studies assessed coexistent AIT
and one also examined coexistent JRA.47 Comorbid AIT
prevalence among the IDDM cases ranged from 0% to 24%.
The study with the second highest prevalence40 was a long-
term follow-up assessment of adults who had been diagnosed
with IDDM as children or adolescents; the other studies were
conducted in pediatric to young adult populations. None of the
studies was population-based, and the only controlled study45
found no cases of AIT in the control group of “healthy” children,
although it is unclear whether the latter category excluded
children with prevalent clinical thyroid disease.
Multiple Sclerosis
Seven studies were included,59–65 some of which ex-
plored more than one comorbid disease. The coexistence of
RA was assessed in 5 studies,59–62,64 with prevalence esti-
mates ranging from 0.35% to 2.4%; a sixth study65 that
assessed comorbid JRA found 0.28% prevalence. Comorbid
RA among patients with MS was the only disease combina-
tion for which there was no evidence of heterogeneity among
studies (P  0.17). The weighted mean prevalence of RA in
patients with MS was 0.63% (excluding the JRA study). Two
studies61,64 had control groups; one found no cases of comor-
bid RA among hospital-based controls, and the other found
an OR of less than 1.0 for comorbid RA among MS cases
versus spouse or friend controls, although the CIs were wide
and overlapped one. A third study62 documented an SPR of
0.60 (95% CI  0.2–1.41), but the reference values were derived
from geographic regions outside of the MS study area.
IDDM coexistence was assessed in 6 studies,59,61–65
with prevalence estimates ranging from 0% to 2.6%. There
was no evidence for an association between IDDM and MS in
the 2 controlled studies.61,64 However, the study that included
referent data from its source population found an increased
association between IDDM and MS.63
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Five studies examining the prevalence of coexistent AIT
among MS cases documented estimates ranging from 0.48% to
3.9%.59,60,62,64,65 Neither study with referents or controls found
evidence of association between AIT and MS.62,64
Autoimmune Thyroiditis
Six studies included AIT as the index disease.66–71 All
assessed comorbid RA, with prevalence estimates ranging from
1.4% to 17.6%. There was no consistent trend for association
between RA and AIT in the 4 controlled studies.68–71
Comorbidity of Autoimmune Diseases
Within Families
Nine studies examined coexistent disease among family
members of index disease cases, only 2 of which did not
report proband data.72,73
Rheumatoid Arthritis
Three controlled studies assessed IDDM prevalence
among family members of RA cases21,22,72; a fourth study
was conducted among family members of JRA cases.73 The
data suggest an increased prevalence of IDDM among family
members of patients with RA or those with JRA versus
relatives of controls. Findings from the JRA study indicate an
increased odds of AIT in the case versus control relatives, but
no association for MS.
Insulin-Dependent Diabetes Mellitus
A single study47 examined the coexistence of the se-
lected autoimmune diseases among family members of pa-
tients with IDDM. The prevalences of comorbid JRA and
AIT among first-degree family members were 0.97% and
2.7%, respectively.
Multiple Sclerosis
Four studies assessed IDDM in relatives of pro-
bands,61,63–65 with a suggestion of increased prevalence of
IDDM among relatives of MS probands, based on 2 con-
trolled studies61,64 and a third with referent population data.63
Three of the studies also assessed RA; there was lack
of association for RA among relatives of MS probands in
the 2 controlled studies.61,64 Two studies assessed AIT; the
only controlled study found increased odds of AIT among
relatives of MS probands versus control relatives.64
Autoimmune (Hashimoto) Thyroiditis
We found no family studies with AIT as the index
disease meeting eligibility criteria for this review.
DISCUSSION
This review focuses on 4 TH1-associated autoimmune
disorders. The concept that autoimmune diseases tend to
coexist is fairly well established in the clinical community,
although based largely on anecdotal evidence. Further con-
jecture that TH1-predominant conditions in particular might
be expected to correlate with one another adds impetus to the
need to quantify relationships among such diseases. To our
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to evaluate the evidence from observational studies linking a
group of TH1-associated autoimmune diseases.
We chose to focus on studies of clinical autoimmune
disease. We excluded studies in which the index or comorbid
conditions were based on autoantibody seropositivity in the
absence of clinical disease. It is important to draw a distinc-
tion between “autoimmunity” and “autoimmune disease.”
Autoimmunity such as the presence of autoreactive T and B
FIGURE 1. Forest plot displaying
prevalence estimates for comorbid
autoimmune diseases within index
disease populations. Due to substan-
tial heterogeneity between studies,
pooled prevalence estimates are not
presented. The majority of studies
were uncontrolled so measures of
association are not displayed. The
studies with asterisks are those that
involved juvenile patients with rheu-
matoid arthritis.
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lymphocytes (eg, autoantibodies) is not necessarily associ-
ated with pathology or adverse clinical manifestations. In
fact, the concept of autoreactivity has evolved to include the
premise that low levels are physiological and may be in-
volved in lymphocyte selection.74 Furthermore, transient el-
evations in autoantibody levels may occur as a byproduct of
nonautoimmune phenomena such as infections.75,76 The bio-
chemical milieu (eg, cytokine profile) and environmental
factors are thought to be important determinants of whether
autoimmunity progresses to clinical disease.
Our decision to restrict this review to data on clinical
disease was particularly relevant to the issue of thyroid
autoimmunity, because studies examining the presence of
comorbid thyroid autoantibodies accounted for a large num-
ber of exclusions. Although autoantibodies are useful as
diagnostic tools, they have low sensitivity and specificity
when screening for or classifying autoimmune diseases. For
example, the prevalence of thyroid microsomal (peroxidase)
antibodies in the general population may range up to 12% and
even higher among the elderly.77 Furthermore, in a longitu-
dinal, population-based study, Hawkins et al77 determined
that of 135 people with positive thyroid microsomal antibod-
ies at baseline, 53 (39%) were negative at 6 years follow up.
It should be noted that interpretation of autoantibody studies
would need to account for factors such as assay methodology
and sensitivity, and the autoantibody titers used as cutoffs to
indicate positive versus negative results.
Of the 54 studies that met criteria for inclusion in this
review, the majority were reports of uncontrolled series. Due
to substantial heterogeneity among studies, it was inappro-
priate to derive pooled estimates to summarize the data,
except for the prevalence of RA among patients with MS.
Although far from conclusive, the literature suggests some
positive associations between diseases. Data appear to sup-
port an increased prevalence of AIT in both patients with RA
and those with IDDM—a finding that corresponds with com-
mon clinical opinion. The IDDM studies predominantly in-
cluded children and adolescents. Although only one within-
individual IDDM study was controlled, the high prevalence
estimates for comorbid AIT are remarkable given that AIT is
generally found in older individuals. Conversely, one would
expect RA and IDDM to be increased among patients with
AIT if etiologic factors are shared between these diseases.
Overall, the evidence points to an increased prevalence of RA
among patients with AIT, but there are insufficient data to
evaluate comorbid IDDM. An intriguing finding is the sug-
gestion of a modest inverse association between RA and MS
based on studies within patients with MS and relatives of MS
probands. Likewise, the weighted mean prevalence of RA
among patients with MS is lower than conventional estimates
for RA in the general population, although caution should be
applied for this type of comparison. It is even more difficult
to draw inference for the other combinations of diseases
studied. However, it is interesting to note the pattern of
investigations that have been undertaken. Reports related to
patients with IDDM focused almost exclusively on comorbid
AIT, whereas for MS, each of the other autoimmune diseases
was studied. RA and AIT investigations were limited to each
other and IDDM. None of the intraindividual studies looked
at comorbid MS. Furthermore, only 9 family studies were
included.
Numerous factors are likely to have contributed to the
broad spectrum of results. The studies varied considerably in
terms of their underlying populations and structure. Charac-
teristics of the patient populations undoubtedly affect preva-
lence estimates. Sex, age, and, to a lesser extent, race are
known to be strongly associated with autoimmune diseases,
making it critical to account for these factors. Although most
studies provided summary statistics for age and sex, the
analyses did not adjust for their confounding effects. Infor-
mation on race was reported in only a few instances. Duration
of index disease may also be a key issue, although many of
the reports did not include such data. Study designs also
differed; few of the studies were population-based, and sev-
eral of the hospital- or clinic-based series did not describe
their selection procedures. The extent to which the data are
generalizable from the tertiary care setting must be consid-
ered, because a substantial proportion of the studies was
based on such populations. Conditions such as autoimmune
thyroid disorders may also fail to reach hospital attention.
Alternatively, the possibility of surveillance bias must be
entertained in that the rate of detection of comorbid condi-
tions may increase during the diagnosis or clinical manage-
ment of chronic conditions such as those included in this
review.
Interestingly, studies involving MS index cases tended
to have larger sample sizes, and more often included popu-
lation-based data, in comparison with studies for other dis-
eases. Correspondingly, as depicted in Figure 1, the ranges of
prevalence estimates for comorbid diseases among MS index
patients were considerably narrower than for other disease
combinations, and there was lack of evidence for heteroge-
neity between studies of RA among MS index cases.
Varying diagnostic criteria were used for the classifi-
cation of cases, and, over time, the characteristics of diag-
nostic tests evolved (eg, autoantibody assays). Because in
general, the sensitivity of tests improves over time, preva-
lence rates could spuriously increase. These changes are
likely to have had particular influence on the diagnosis of
autoimmune thyroiditis. For instance, there has been a shift in
practice from histologic diagnosis to diagnosis based on
clinical and laboratory evidence. Because the studies spanned
approximately 75 years, however, genuine changes in prev-
alence and incidence rates are also plausible. For serologic
studies relying on laboratory testing as the basis for AIT
diagnosis, it is often unclear whether treatments affecting
thyroid function (including thyroid replacement therapy)
were accounted for. Also, nomenclature and classification
schemes for thyroid diseases have not been standardized to
the same extent as for other diseases considered in this
review. In fact, not one of the studies included here referred
to published guidelines for the diagnosis of thyroid disease.
This seriously affects the comparability among epidemiologic
studies, which use various terminology and case definitions.
Moreover, it is important not to group overt and subclinical
hypothyroidism, because the latter indicates a mild state of
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thyroid hypofunction rather than a disease entity.18 In addi-
tion, some studies define the term “subclinical hypothyroid-
ism” as elevated serum TSH, whereas others consider it to
mean elevated serum TSH in conjunction with thyroid auto-
antibodies.78
Given the low prevalence of many autoimmune dis-
eases, individual studies tend to have inadequate sample sizes
and power to demonstrate whether an association exists
between various autoimmune diseases. Unfortunately, we
could not perform meta-analyses given the variability be-
tween studies. Publication bias is another issue in that studies
with positive results may be more likely to be published. For
the present topic, this problem may have been mitigated by
the fact that in many studies, the association between auto-
immune diseases was not intended as a primary outcome but
rather as supplemental information. Case ascertainment may
also differ in studies designed to look at “any autoimmune
disease” versus those with a predesignated list of diseases.
These issues make it difficult to draw firm conclusions
about the extent of coexistence of the selected autoimmune
diseases within individuals and families. Further research in this
area can be useful, because it is clear that the co-occurrence of
autoimmune diseases is likely to be as much due to common
environmental factors as genetic susceptibility.
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